-
Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine.
Brain Res. 1973 Jun 15;55(2):369-82
PMID: 4145950
-
Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function.
Biol Psychiatry. 2006 Nov 15;60(10):1111-20
PMID: 16806100
-
Hyperdopaminergic tone erodes prefrontal long-term potential via a D2 receptor-operated protein phosphatase gate.
J Neurosci. 2009 Nov 11;29(45):14086-99
PMID: 19906957
-
Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat.
Neurochem Int. 2008 Feb;52(3):457-69
PMID: 17881090
-
Cortico-subcortical neuromodulation involved in the amelioration of prepulse inhibition deficits in dopamine transporter knockout mice.
Neuropsychopharmacology. 2012 Oct;37(11):2522-30
PMID: 22781838
-
Neuropsychological outcomes across the day in children with attention-deficit/hyperactivity disorder treated with atomoxetine: results from a placebo-controlled study using a computer-based continuous performance test combined with an infra-red motion-tracking device.
J Child Adolesc Psychopharmacol. 2011 Oct;21(5):433-44
PMID: 22040189
-
Hyperactivity in novel environment with increased dopamine and impaired novelty preference in apoptosis signal-regulating kinase 1 (ASK1)-deficient mice.
Neurosci Res. 2010 Mar;66(3):313-20
PMID: 20006657
-
Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters.
Pharmacol Ther. 2011 Mar;129(3):352-68
PMID: 21147164
-
Neurobiology of ADHD.
Neuropharmacology. 2009 Dec;57(7-8):579-89
PMID: 19627998
-
Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry.
Pharmacol Biochem Behav. 2008 Aug;90(2):250-60
PMID: 18272211
-
Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD.
Psychol Bull. 1997 Jan;121(1):65-94
PMID: 9000892
-
Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate.
Curr Neuropharmacol. 2008 Dec;6(4):322-8
PMID: 19587853
-
Current perspectives of the roles of the central norepinephrine system in anxiety and depression.
Depress Anxiety. 2010 Apr;27(4):339-50
PMID: 19960531
-
Assaying dissociable elements of behavioural inhibition and impulsivity: translational utility of animal models.
Curr Opin Pharmacol. 2011 Oct;11(5):534-9
PMID: 21763200
-
Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice.
Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7699-704
PMID: 9636213
-
Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters.
Neuropsychopharmacology. 2004 Oct;29(10):1790-9
PMID: 15226739
-
Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons.
Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):11035-40
PMID: 12958210
-
Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.
Pharmacol Biochem Behav. 2011 Aug;99(2):211-6
PMID: 21295057
-
Behavioral alterations associated with targeted disruption of exons 2 and 3 of the Disc1 gene in the mouse.
Hum Mol Genet. 2011 Dec 1;20(23):4666-83
PMID: 21903668
-
Animal models of attention-deficit/hyperactivity disorder.
Biol Pharm Bull. 2011;34(9):1373-6
PMID: 21881220
-
On inhibition/disinhibition in developmental psychopathology: views from cognitive and personality psychology and a working inhibition taxonomy.
Psychol Bull. 2000 Mar;126(2):220-46
PMID: 10748641
-
Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.
Science. 1999 Jan 15;283(5400):397-401
PMID: 9888856
-
Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD).
Psychopharmacology (Berl). 2009 Jan;202(1-3):531-9
PMID: 18818905
-
Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.
Neuropsychopharmacology. 2002 Nov;27(5):699-711
PMID: 12431845
-
Impairment of cliff avoidance reaction induced by subchronic methamphetamine administration and restraint stress: comparison between two inbred strains of rats.
Prog Neuropsychopharmacol Biol Psychiatry. 1998 Aug;22(6):1023-32
PMID: 9789885
-
Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene.
Neuropsychopharmacology. 2005 Oct;30(10):1818-31
PMID: 15856082
-
Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
J Neurochem. 2010 Jul;114(1):259-70
PMID: 20403082
-
Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder.
Biol Psychiatry. 2003 Dec 15;54(12):1465-8
PMID: 14675812
-
Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice.
Neuropsychopharmacology. 2006 Oct;31(10):2132-9
PMID: 16407898
-
Profound neuronal plasticity in response to inactivation of the dopamine transporter.
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):4029-34
PMID: 9520487
-
Prepulse inhibition and genetic mouse models of schizophrenia.
Behav Brain Res. 2009 Dec 7;204(2):282-94
PMID: 19397931
-
Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition.
Neurosci Biobehav Rev. 2010 Jan;34(1):50-72
PMID: 19615404
-
Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.
Neurosci Biobehav Rev. 2007;31(4):597-618
PMID: 17316796
-
Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine.
Neuropharmacology. 2013 Jan;64:348-56
PMID: 22809709
-
The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders.
Br J Pharmacol. 2011 Oct;164(4):1301-21
PMID: 21410459
-
Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.
Cell. 2000 Mar 31;101(1):57-66
PMID: 10778856
-
Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania.
J Psychopharmacol. 2011 Jul;25(7):934-43
PMID: 21421642
-
The neuropharmacology of impulsive behaviour.
Trends Pharmacol Sci. 2008 Apr;29(4):192-9
PMID: 18304658
-
Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.
Eur J Pharmacol. 1989 Aug 3;166(3):359-66
PMID: 2553433
-
Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists.
J Neurosci. 2001 Jan 1;21(1):305-13
PMID: 11150348
-
Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice.
Behav Pharmacol. 2000 Jun;11(3-4):279-90
PMID: 11103882
-
Prostaglandin E receptor EP1 controls impulsive behavior under stress.
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16066-71
PMID: 16247016
-
Motor behaviour deficits and their histopathological and functional correlates in the nigrostriatal system of dopamine transporter knockout mice.
Neuroscience. 2003;116(4):1123-30
PMID: 12617953
-
Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter.
J Neurosci. 1998 Apr 1;18(7):2697-708
PMID: 9502827